Related Experiment Videos
Effects of IL-7 and IL-2 on highly enriched CD56+ natural killer cells. A comparative study
Insights
Interleukin-7 (IL-7) significantly enhances lymphokine-activated killer (LAK) cell activity and proliferation in purified CD56+ cells, demonstrating potent immune modulation effects.
Area of Science:
- Immunology
- Cell Biology
- Cytokine Signaling
Background:
- Interleukin-7 (IL-7) is known to induce low lymphokine-activated killer (LAK) cell activity in peripheral blood mononuclear cells (PBMCs).
- The specific effects of IL-7 on distinct immune cell subsets, particularly CD56+ cells, require further elucidation.
Purpose of the Study:
- To investigate the impact of IL-7 on LAK activity and proliferation in immunomagnetically purified CD56+ cells.
- To compare the effects of IL-7 with Interleukin-2 (IL-2) on CD56+ cell functions.
Main Methods:
- Immunomagnetic purification of CD56+ cells from peripheral blood.
- Assessment of LAK activity and cellular proliferation in response to IL-7 and IL-2.
- Analysis of tumor necrosis factor receptor (TNFR) and IL-2 receptor alpha (IL-2Rα) expression.
- Quantification of cytokine production (TNF, IL-2, IL-6).
Main Results:
- IL-7 induced high LAK activity in CD56+ cells, comparable to IL-2.
- IL-7 significantly enhanced proliferation in CD56+ cells, with a synergistic effect observed with suboptimal IL-2.
- IL-7 stimulation led to increased IL-2Rα expression and comparable 75-kDa TNFR expression to IL-2.
- Low levels of TNF were produced by IL-7-stimulated cells, contrasting with higher production induced by IL-2.
Conclusions:
- IL-7 exerts profound and direct effects on CD56+ cells, enhancing their LAK activity and proliferative capacity.
- IL-7 serves as a potent immune modulator for CD56+ cells, with potential therapeutic implications.
- The distinct yet comparable effects of IL-7 and IL-2 highlight their unique roles in immune regulation.
Abstract:
IL-7 has been shown to induce low levels of lymphokine-activated killer cell (LAK) activity in bulk PBMC populations. We report here that immunomagnetically purified CD56+ cells from peripheral blood generated high LAK activity in response to IL-7. The LAK activity induced by IL-7 was comparable to, or slightly lower than, the LAK activity induced by IL-2. When analyzing cells from the same donor, no detectable LAK-generating effect of IL-7 was registered in the PBMC population, in contrast to a substantial effect in the CD56+ population. IL-2 induced 8- to 15-fold higher proliferative activity in CD56+ cells, relative to IL-7. At suboptimal concentrations of IL-2, IL-7 had a synergistic effect on the proliferation. IL-2-neutralizing antibodies did not abrogate the IL-7-induced proliferation or LAK generation. Both IL-7 and IL-2 induced comparable levels of 75-kDa TNFR expression, whereas IL-2R alpha expression was higher in IL-7-stimulated CD56+ cells. Low levels of TNF were produced in response to IL-7 at day 5, as opposed to a 50-fold higher TNF production in response to IL-2. No IL-2 or IL-6 production was detected. Our data indicate that IL-7 has profound and direct effects on CD56+ cells.